SCHEMBL1336732

SCHEMBL1336732

CC(C)(C)c1cc(C(C)(C)C)c(O)c(N=Nc2ccc(Cl)cc2[N+](=O)[O-])c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.42
KMT2A Q03164 7/20 0.42
HTT P42858 4/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
GALR3 O60755 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 1/20 0.42
MAPT P10636 6/20 0.40
MAPK1 P28482 5/20 0.39
SAE1 Q9UBE0 2/20 0.39
UBA2 Q9UBT2 2/20 0.39
UBE2I P63279 1/20 0.39
LMNA P02545 4/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30200284 0.85 MEN1 (0.40) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL29603532 0.85 MEN1 (0.41) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL6870910 0.85 MEN1 (0.40) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL7759721 0.85 MEN1 (0.41) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL6870907 0.85 MEN1 (0.40) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL30200323 0.85 MEN1 (0.40) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL7759727 0.85 MEN1 (0.41) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL1336669 0.83 ALDH1A1 (0.42) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL13021477 0.79 MEN1 (0.35) MEN1KMT2AHTTL3MBTL1GALR3
SCHEMBL10340171 0.79 MEN1 (0.35) MEN1KMT2AHTTL3MBTL1GALR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8425891-B2 UV-absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2013-04-23 US disclosed
US-20130032757-A1 UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2013-02-07 US disclosed
US-8323631-B2 UV-absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2012-12-04 US disclosed
US-20110272645-A1 UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2011-11-10 US disclosed
US-8043607-B2 UV-absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2011-10-25 US disclosed
US-20100012889-A1 UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110272645-A1 UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS CRYAB, DDT, CRYZ MEN1 2815/4885KMT2A 2776/4885HTT 1471/4885
US-20100012889-A1 UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS CRYAB, DDT, CRYZ MEN1 2815/4885KMT2A 2776/4885HTT 1471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.